A detailed history of Integrated Wealth Concepts LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 2,093 shares of NBIX stock, worth $262,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,093
Previous 2,094 0.05%
Holding current value
$262,692
Previous $288,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$130.86 - $143.19 $130 - $143
-1 Reduced 0.05%
2,093 $288,000
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $4,433 - $4,887
34 Added 1.65%
2,094 $288,000
Q4 2023

Feb 13, 2024

BUY
$106.07 - $132.76 $1,060 - $1,327
10 Added 0.49%
2,060 $271,000
Q3 2023

Nov 15, 2023

BUY
$94.02 - $117.1 $192,741 - $240,055
2,050 New
2,050 $230,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.